Anthony Dunning Martinez MD AAHIVS, FAASLD
Hepatology & Liver Transplantation
Medical Director Hepatology
Join to view full profile
462 Grider stBuffalo, NY 14215
Phone+1 716-898-6410
Fax+1 716-898-3363
Dr. Martinez is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
New York Presbyterian Hospital (Columbia Campus)Residency, Gastroenterology, 2019 - 2025- New York Presbyterian Hospital (Cornell Campus)Fellowship, Addiction Medicine, 2006 - 2007
Roger Williams Medical CenterResidency, Internal Medicine, 2003 - 2006
Universidad Autonoma de GuadalajaraClass of 2002
Certifications & Licensure
CA State Medical License 2008 - Present
NY State Medical License 2005 - 2028
NV State Medical License 2011 - 2013
American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Fellow American Association for the Study of Liver
Publications & Presentations
PubMed
- 1 citationsLeveraging opportunities for treatment/user simplicity (LOTUS): Navigating the current treatment landscape for achieving hepatitis C virus elimination among persons wh...Mark S Sulkowski, Anthony Martinez, Gia L Tyson, Kathleen Scholz, Ricardo A Franco
Journal of Viral Hepatitis. 2024-06-01 - 1 citationsReported adverse events related to use of hepatitis C virus direct-acting antivirals with opioids: 2017-2021.Anthony Martinez, Tipu Khan, Douglas E Dylla, John Marcinak, Michelle Collins
Harm Reduction Journal. 2023-10-01 - 3 citationsShorter Duration Hepatitis C Virus Treatment is Associated with Better Persistence to Prescription Refills in People Who Inject Drugs: A Real-World Study.Anthony Martinez, Wei-Han Cheng, Steven E Marx, Shivaji Manthena, Douglas E Dylla
Advances in Therapy. 2023-08-01
Press Mentions
Atea Pharmaceuticals to Host Virtual HCV KOL Panel Event on November 13, 2025October 22nd, 2025- Atea Pharmaceuticals to Host Virtual HCV KOL Panel on May 14, 2025May 1st, 2025
Better Outcomes Tied to More HCV Treatment for People Who Inject DrugsJuly 11th, 2022
Professional Memberships
- Member
- AASLDMember
- EASLMember
- INHSUMember
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
